Q-Centrix, a portfolio company of Sterling Partners, has named Max Broedlow as chief financial officer. Previously, he worked at Strata Decision Technology LLC. Based in Portsmouth, New Hampshire and Chicago, Q-Centrix is a medical tech company.
CHICAGO, IL and PORTSMOUTH, NH–(Marketwired – May 14, 2015) – Q-Centrix, LLC today announced the appointment of Max Broedlow to the position of Chief Financial Officer.
Q-Centrix, owned by Sterling Partners, a middle market private equity firm, leads the healthcare quality market by combining its clinical workforce of more than 600 quality information specialists with market-leading technology to surveil, abstract, analyze and improve hospital quality. After more than five million quality data abstractions and 500 client implementations, the organization has become the market leader. Broedlow will report to Milton Silva-Craig, Q-Centrix Chief Executive Officer.
“Max’s demonstrated track record as a successful CFO, combined with his healthcare technology experience, made him the perfect candidate to step into this important role on our leadership team,” said Silva-Craig. “He’s seasoned, data-driven and understands how to drill down to the details of finance and business issues. We’re excited to have found someone who is so capable and eager to contribute to the growth and scale of a fast-growing business like ours.”
Broedlow has a strong history of growing small and large businesses, both in healthcare and financial services. He joins Q-Centrix from Strata Decision Technology LLC, a healthcare software company specializing in SaaS solutions for financial and business analytics and decision support in healthcare. After three years leading the financial functions at Strata, Broedlow played an instrumental role in the sale of the company to Roper Industries in early 2015. Prior to Strata, Broedlow worked for SunGard Data Systems, a leading software and IT company. Broedlow’s financial roles at SunGard included serving as Division CFO for Financial Systems, overseeing entities that spanned in size from $20m business units up to a $1.5 billion division and was the financial lead for due diligence and post-integration of more than 20 acquisitions. Prior to SunGard, Broedlow led both Finance and Administration for Cyvent, a healthcare software company serving the healthcare payer market.
“I’m excited to join a company that empowers quality professionals, physicians and administrators to unite for quality improvement through the use of innovative technology and services,” says Broedlow. “It’s a privilege to be part of an organization committed to positively impacting an industry.”
Broedlow holds a Bachelor of Science in Accounting from Illinois State University and a Master of Business Administration from Northwestern University’s Kellogg School of Management.
Q-Centrix aims to improve patient care in the U.S. through the use of market-leading technology coupled with the industry’s largest and broadest team of nurse-educated, quality information specialists. Conducting in excess of a million quality data abstractions annually, Q-Centrix is a comprehensive quality partner to hundreds of hospitals, providing clinical surveillance, abstraction, analysis and improvement services.
To learn more about the leader in clinical surveillance and quality data abstraction, visit www.q-centrix.com.
About Sterling Partners:
Q-Centrix was welcomed into Sterling Partners’ portfolio in December 2013. Sterling focuses on partnering with like-minded founders and entrepreneurs, and investing growth capital in small- and mid-market companies in industries with positive, long-term trends.